Apr 8, 2014 ... Inc., according to Takeda (In Re: Actos [Pioglitazone] Products Liability Litigation, ... 6:11-md-2299, Allen v. Takeda Pharmaceuticals North America Inc., et al., No. ... Allen is represented by Richard Arsenault of Neblett, Beard ...


... AMERICA v. ALLERGAN, INC., ET AL, case number 2:08-cv-05135, from Pennsylvania Eastern Court. ... RICHARD D. RASKIN, SIDLEY AUSTIN LLP TERMINATED: 07/03/2012 .... TAKEDA PHARMACEUTICALS NORTH AMERICA , INC.


Oct 27, 2014 ... Ltd. and Eli Lilly & Co. over the diabetes drug Actos to $36.8 million, ruling ... a $9 billion punitive damages award against Takeda Pharmaceutical Co. ... behavior,” said Richard Arsenault of Neblett Beard & Arsenault LLP, lead ... The case is Allen et al. v. ... v. Takeda Pharmaceuticals North America Inc et al ...


Dec 19, 2018 ... TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al, No. 3:2018cv01994 - Document 72 ...


Jun 7, 2018 ... ... Company Limited, et al. v. Zydus Pharmaceuticals (USA) Inc., et al. Tags: ... Brief for the United States of America as Amici Curiae (316.3 KB) ...


Nancy COOPER, Individually and as Successor, etc., Plaintiffs and Appellants, v. TAKEDA PHARMACEUTICALS AMERICA, INC., et al., Defendants and ...


Apr 21, 2014 ... TorHoerman Law LLC. Abrams, Richard C. v. Takeda Pharmaceuticals America, Inc., et al., 2012-L-014472. Napoli Bern Ripka Shkolnik LLP.


Feb 15, 2014 ... formerly known as Takeda Pharmaceuticals North America. Incorporated; ELI ... Richard J. Arsenault ... Pharmaceuticals North America. Inc. Takeda Development Center ... v. TABLE OF CONTENTS. Certificate of Interested Persons . ...... Jr., et al., Sanctions for E–Discovery Violations: By the Numbers, 60 .


Sep 3, 2018 ... Boehringer Ingelheim Pharmaceuticals, Inc. v. ... Valeant Pharmaceuticals v. ..... Defendants: Next Step Laboratories Corp. and Richard Rigg ... U.S.A., Inc., Takeda Pharmaceuticals International AG, and Takeda Pharmaceuticals America , Inc. .... Valeant Pharmaceuticals Luxembourg S.A.R.L. et al. v.